Clinical Trial Update: Prevention of Docetaxel Induced Dacryostenosis [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating prevention of docetaxel-induced dacryostenosis (epiphora) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epiphora

Drugs mentioned

• Docetaxel (Taxotere) (docetaxel)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Epiphora | Phase 1 | Status: COMPLETED